WINDTREE THERAPEUTICS INC /DE/ Quarterly Liabilities and Equity in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Windtree Therapeutics Inc /De/ quarterly Liabilities and Equity history and growth rate from Q4 2010 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Liabilities and Equity for the quarter ending September 30, 2024 was $30.4M, a 15.6% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $30.4M -$5.61M -15.6% Sep 30, 2024 10-Q 2024-11-26
Q2 2024 $28.7M -$11.9M -29.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $30.1M -$5.08M -14.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $32.4M -$5.55M -14.6% Dec 31, 2023 10-Q 2024-11-26
Q3 2023 $36.1M -$12M -25% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $40.6M -$11.2M -21.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $35.2M -$31.9M -47.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $38M -$36.8M -49.3% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $48.1M -$36.7M -43.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $51.8M -$39.1M -43% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $67.1M -$68.8M -50.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $74.8M -$38.1M -33.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $84.8M -$33.7M -28.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $90.9M -$37.5M -29.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $136M +$22.9M +20.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $113M -$6.09M -5.12% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $119M +$17.9M +17.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $128M +$23.1M +21.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $113M +$1.37M +1.23% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $119M -$423K -0.35% Dec 31, 2019 10-K 2021-03-29
Q3 2019 $101M +$98.7M +5079% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $105M +$103M +5218% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $112M +$109M +3662% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $119M +$116M +3467% Dec 31, 2018 10-K 2020-04-03
Q3 2018 $1.94M -$2.71M -58.3% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $1.98M -$3.85M -66% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $2.97M -$8.74M -74.7% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 $3.35M -$6.35M -65.5% Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 $4.66M -$11.8M -71.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $5.83M -$19.2M -76.7% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 $11.7M -$23M -66.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $9.7M -$34.7M -78.1% Dec 31, 2016 10-K 2018-04-17
Q3 2016 $16.4M -$36.3M -68.8% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $25M -$3.2M -11.4% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 $34.7M -$3.41M -8.95% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $44.4M -$3.12M -6.57% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $52.7M -$5.58M -9.57% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $28.2M -$41.3M -59.4% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $38.1M -$41.4M -52% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $47.5M -$41.8M -46.8% Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 $58.3M +$34.7M +147% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $69.5M +$35.6M +105% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $79.5M +$50.3M +173% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $89.3M +$59.4M +198% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $23.6M -$16.1M -40.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $33.9M -$15.3M -31.1% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $29.2M -$28.6M -49.5% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $29.9M +$16.6M +125% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $39.8M +$21M +112% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $49.2M +$23.9M +94.8% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $57.7M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $13.3M -$1.21M -8.34% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $18.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $25.2M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $14.5M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.